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Abstract
Background: Monocyte subpopulations distinguished by differential expression of chemokine receptors CCR2 and CX3CR1
are difficult to track in vivo, partly due to lack of CCR2 reagents.
Methodology/Principal Findings: We created CCR2-red fluorescent protein (RFP) knock-in mice and crossed them with
CX3CR1-GFP mice to investigate monocyte subset trafficking. In mice with experimental autoimmune encephalomyelitis,
CCR2 was critical for efficient intrathecal accumulation and localization of Ly6C
hi/CCR2
hi monocytes. Surprisingly,
neutrophils, not Ly6C
lo monocytes, largely replaced Ly6C
hi cells in the central nervous system of these mice. CCR2-RFP
expression allowed the first unequivocal distinction between infiltrating monocytes/macrophages from resident microglia.
Conclusion/Significance: These results refine the concept of monocyte subsets, provide mechanistic insight about
monocyte entry into the central nervous system, and present a novel model for imaging and quantifying inflammatory
myeloid populations.
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Introduction
Monocytes, the blood-borne precursors of tissue macrophages
and dendritic cells (DCs) [1–5], are critical mediators of innate and
adaptive immune functions [6,7]. Monocytes can be divided into at
least two subsets based on expression of the surface marker Ly6C in
mice [2,8] and three subsets based on CD14/CD16 expression in
humans [9–11]. The Ly6C
hi [12,13] and CD14
+/CD16
2 subsets
[14] express chemokine receptor 2 (CCR2) and low levels of
CX3CR1 [2] and appear to be functionally equivalent across
species. Conversely, the Ly6C
lo and CD14/CD16
+ subsets lack
CCR2 but express high levels of CX3CR1 [2,3,14,15]. Ly6C
hi cells
enter tissues in response to injury or infection and traffic back to
draining lymph nodes [2,3]. Within inflamed tissues, Ly6C
hi cells
differentiate into macrophages or conventional DCs [1,16]. In
contrast,Ly6C
locellspatrolthe vascularendotheliallumen,respond
early to inflammatory insults, and are hypothesized to contribute to
wound healing in the later stages of inflammation [1,16]. CCR2 is
thought to mediate the trafficking of Ly6C
hi cells [2,12,13,16,17],
while CX3CR1 may contribute to Ly6C
lo cell migration [16],
although other chemokine receptors such as CCR5 also may be
important [18].
The roles of particular monocyte subsets likely vary in different
disease models and different organs [19–22]. Further complicating
the picture, resident macrophages and DCs are difficult to
distinguish from macrophages and DCs derived from infiltrating
monocytes. The study of monocyte subsets has been greatly aided
by the use of CX3CR1-GFP knock-in reporter mice [2,3,23], but
the lack of reagents to visualize CCR2-expressing cells, particularly
in tissue sections, has restricted tracking monocyte subsets in vivo.
To investigate monocyte trafficking in vivo, we generated red
fluorescent protein (RFP)-CCR2 knock-in mice, crossed them with
CX3CR1-GFP mice, and analyzed them in models of sterile
peritonitis and multiple sclerosis using flow cytometry and
evaluation of tissue sections. The results provide direct evidence
that the presence of CCR2-directed Ly6C
hi monocytes dictates the
distribution and composition of leukocyte infiltrates in both the
brain and spinal cord of mice with experimental autoimmune
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13693encephalitis (EAE). The relative expression of CX3CR1-GFP and
CCR2-RFP allowed us for the first time to distinguish monocyte/
macrophage subsets and discriminate between resident microglia
and infiltrating monocyte-derived macrophages in the brain.
Results
Generation of CCR2
RFP knock-in mouse
We used an expression cassette with a cDNA that encoded
monomeric RFP [24] to replace the first 279 base pairs of the
amino terminus of the CCR2 open reading frame (Figure 1A). The
CCR2 promoter in the targeting vector was unchanged up to the
first methionine of the open reading frame, as determined by
sequence analysis. The RFP gene construct included a poly-A
termination signal to exclude the remainder of the CCR2
sequence from the mature transcript. Homologous recombinations
in embryonic stem cells and mouse derivation were accomplished
by standard methods [25], and the neomycin-resistance gene was
deleted. Southern blot hybridization confirmed the correct
genomic structure (Figure 1B). Flow cytometric analysis of
Ccr2
RFP/+ and Ccr2
RFP/RFP peripheral blood cells stained for cell-
surface CCR2 (Figure 1C) confirmed bi-allelic expression of
CCR2 and RFP in heterozygous mice and deletion of CCR2 in
Ccr2
RFP/RFP homozygous mice. All CCR2-positive cells were RFP
positive, but some RFP-positive cells failed to express CCR2 at the
cell surface.
RFP and CCR2 RNA expression in leukocytes
CCR2 and RFP transcript levels were determined by
quantitative RT-PCR of cell populations isolated by fluores-
cence-activated cell sorting (FACS). In blood cells from Ccr2
RFP/+
mice, CCR2 and RFP mRNA levels tracked closely, as expected
for bi-allelic expression from the CCR2 promoter (Figure 2A).
RFP transcripts were undetectable in wildtype (WT) cells, and
CCR2 was absent in Ccr2
RFP/RFP cells. Monocytes that stained
positively for surface CCR2 invariably contained RFP protein and
expressed three- to fourfold more CCR2 and RFP transcripts than
monocytes not expressing cell-surface CCR2 (Figure 2A). Prelim-
inary flow cytometry surveys of Ccr2
RFP/+ mice indicated that some
natural killer (NK) and T cells also were positive for RFP (85–95%
and 5–10% respectively; data not shown). NK and T cells were
sorted into RFP-positive and RFP-negative fractions. Despite
lacking CCR2 immunoreactivity by flow cytometry, T cells and
NK cells from WT and Ccr2
RFP/+ mice contained CCR2
transcripts, and CCR2 and RFP mRNA levels were similar in
both cell types (Figure 2B). These results indicate possible post-
transcriptional control of CCR2 expression.
RFP and CCR2 protein expression in monocyte
subsets
To evaluate RFP and CCR2 expression in blood monocyte
subsets in an inflammatory setting, we crossed Ccr2
RFP mice with
apolipoprotein E–deficient (Apoe
2/2) mice, fed them a high-fat diet
for 8 weeks, and analyzed RFP and CCR2 surface expression in
CD115
+ monocytes by flow cytometry (Figure 2C). Both Ly6C
hi
and Ly6C
lo monocytes were RFP-positive, but the Ly6C
hi cells
were significantly brighter (Figure 2D and E). Approximately 86%
of Ly6C
hi monocytes expressed cell-surface CCR2 (Figure 2F), as
did 18% of Ly6C
lo monocytes (Figure 2G). These results indicate
that RFP expression can predict CCR2 expression levels in
monocytes.
Cytoplasmic CCR2 in lymphocytes and monocyte subsets
Some CCR2 surface-negative leukocytes contained abundant
levels of CCR2 mRNA (and RFP protein and mRNA) (Figure 2).
To ask whether Ly6C
lo monocytes contained cytoplasmic CCR2
that failed to traffic to the cell surface, we compared CCR2
staining on permeabilized and nonpermeabilized monocytes by
FACS (Figure S1). Monocytes from CCR2 knockout mice served
as negative controls. In Ly6C
hi monocytes, permeabilization
increased the CCR2 signal twofold, indicating that approximately
50% of total CCR2 was cytoplasmic, but had little effect on CCR2
staining in Ly6C
lo monocytes. Similarly, intracellular CCR2 was
undetectable in T cells or NK cells, despite the presence of CCR2
mRNA (data not shown). These results suggest that T cells, NK
cells and some Ly6C
lo monocytes may be capable of expressing
CCR2 protein but do not do so constitutively.
Analysis of monocytes from Ccr2
RFPCx3cr1
GFP mice
To evaluate blood monocyte subsets for expression of CCR2 or
CX3CR1 during chronic systemic inflammation, we crossed
Ccr2
RFP/RFP mice with Cx3cr1
GFP/GFP mice [23] and examined
Ccr2
RFP/+Cx3cr1
GFP/+Apoe
2/2 mice fed a high-fat diet for 8 weeks.
Ly6C
hi and Ly6C
lo monocytes were both GFP positive
(Figure 2H). Ly6C
lo cells were clearly brighter than Ly6C
hi cells,
which had a wider range of GFP intensities. Both Ly6C
hi and
Ly6C
lo monocytes were RFP positive, but Ly6C
hi cells were
brighter (Figure 2I). There was a broad range of RFP intensities in
the Ly6C
lo monocytes (Figure 2I), though many were as bright as
those in the Ly6C
hi population. We next examined RFP
expression and CCR2 surface staining on monocytes stratified
by their level of Ly6C. As expected from the Ccr2
RFP mice
(Figure 2F,G), virtually all of the Ly6C
hi monocytes were markedly
positive for both RFP and CCR2 staining (Figure 2J). While most
but not all Ly6C
lo monocytes were negative for CCR2 staining,
some Ly6C
lo monocytes expressed CCR2 at levels similar to those
in Ly6C
hi monocytes. Ccr2
RFP/RFP mice served as negative controls
to set the FACS gates for CCR2 staining (Figure 2K).
To investigate the relative contributions of CCR2 and
CX3CR1 to monocyte/macrophage recruitment in vivo, we used
a mouse model of thioglycollate-induced peritonitis. In naive mice,
the vast majority of F4/80
hi peritoneal macrophages were negative
for GFP and RFP and were probably resident macrophages
(Figure 3A). After instillation of thioglycollate for 24 h to induce
peritonitis, Ccr2
RFP/+Cx3cr1
GFP/+ F4/80
dim monocytes were ac-
tively recruited to the peritoneum, and almost all expressed high
levels of both RFP and GFP (Figure 3A). Recruited monocytes
were Ly6C
hi (not shown). In WT and Ccr2
RFP/+Cx3cr1
GFP/+ mice,
equal numbers of F4/80
+ monocyte/macrophages accumulated in
the peritoneum (Figure 3B). Monocyte recruitment was little affected
by loss of the second CX3CR1 allele (Ccr2
RFP/+Cx3cr1
GFP/GFP), but
was markedly reduced by loss of the second CCR2 allele (Ccr2
RFP/RFP
Cx3cr1
GFP/+) (Figure 3B). Recruitment was indistinguishable in
double-knockout mice (Ccr2
RFP/RFPCx3cr1
GFP/GFP) and CCR2 knock-
outs (Ccr2
RFP/RFPCx3cr1
GFP/+). Monocyte counts in the blood and
bone marrow were alsoindistinguishableinthe two genotypes.These
results revealed that the vast majority of monocytes recruited to the
peritoneum in response to sterile inflammation are CCR2/CX3CR1
double-positive, although their recruitment is almost exclusively
driven by CCR2. These experiments also demonstrated the feasibility
of using CCR2-RFP and CX3CR1-GFP to track monocyte subsets
in vivo.
Experimental autoimmune encephalomyelitis in CCR2-
deficient mice
To extend these results in an established model of organ-specific
inflammation, we compared Ccr2
RFP/+Cx3cr1
GFP/+ and Ccr2
RFP/RFP
Cx3cr1
GFP/+ mice with EAE by monitoring disease severity
daily for 40 days after immunization. All mice were highly
Novel CCR2-RFP Mice in EAE
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RFP mice. (A) Recombinant targeting strategy. Hatched box represents region of CCR2
deleted by recombination. Triangles represent loxP sites. (B) Southern blot analysis of WT, Ccr2
RFP/+ heterozygous, and Ccr2
RFP/RFP homozygous
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compared in each experiment. In Ccr2
RFP/RFPCx3cr1
GFP/+ mice, the
onset of EAE was delayed by a mean of 4.5 days (day 17.460.6 (SD)
vs. day 12.960.1 in Ccr2
RFP/+Cx3cr1
GFP/+ mice) (Figure 4A). The
maximum disease scores were similarly delayed (day 20.360.5 for
Ccr2
RFP/RFPCx3cr1
GFP/+ mice vs. day 16.660.4 for Ccr2
RFP/+
Cx3cr1
GFP/+ mice), indicating equivalent kinetics of disease evolution
in the two groups (Figure 4B). Peak severity scores were lower in the
CCR2-null mice, but the difference did not reach statistical
significance (p=0.11). A similar delay in onset followed by equivalent
peak severity was observed in Ccr2
RFP/RFPCx3cr1
GFP/GFP mice (data
not shown). The latter finding indicates that the effect of CCR2
deficiency is dominant on a CX3CR1-null background, given the
observation that Cx3cr1
GFP/GFP mice exhibited earlier disease onset
than WT mice [26].
Infiltration by CD115
+ monocytes is reduced in CNS of
CCR2-deficient mice
We previously showed that inflamed EAE tissues contain high
levelsofCCR2 and CX3CR1 ligands [26,27], making this tissueideal
for comparing the trafficking properties of monocytes bearing either
of the two cognate receptors. To characterize the cellular infiltrate in
the CNS of mice with EAE, we used flow cytometry to analyze CNS
leukocytes isolated at the peak of disease severity (Figure 4C and 4D).
Ccr2
RFP/+Cx3cr1
GFP/+ mice allowed us to simultaneously track
CX3CR1-and CCR2-positive cells, and Ccr2
RFP/RFPCx3cr1
GFP/+
mice allowed us to examine the effect of CCR2 deficiency on
monocyte recruitment during EAE. Leukocytes were stained with
antibodies against CD45 to distinguish CD45
hi infiltrating leukocytes
from CD45
lo microglial cells. At peak disease severity, similar
numbers of total and CD45
hi cells were recovered from the brains of
genomic DNA. DNA was digested with PstI, and hybridized with the indicated probe. (C) Flow cytometry analysis of peripheral blood leukocytes (PBL)
from WT, Ccr2
RFP/+, and Ccr2
RFP/RFP mice. Cells were stained with anti-CCR2 antibody MC21. The results are representative of four similar experiments.
doi:10.1371/journal.pone.0013693.g001
Figure 2. Expression of CCR2 and RFP in sorted cell populations. (A) CD115
+ monocytes were sorted by flow cytometry into populations that
did or did not express cell-surface CCR2. Total RNA was isolated, pooled from three mice per genotype, and analyzed for CCR2 mRNA and RFP mRNA
by quantitative RT-PCR. Probe specificity was confirmed with WT and Ccr2
2/2 cells. Expression levels were normalized to beta-actin, and the results
are expressed relative to the concentration of CCR2 mRNA in monocytes expressing cell-surface CCR2. (B) NK and T cells were sorted by flow
cytometry into RFP
+ and RFP
– fractions. Expression of CCR2 and RFP mRNA was characterized as in (A) and normalized to the amount of CCR2 RNA in
the RFP
+ T-cell fraction from Ccr2
+/RFP mice. (C to G) WT, Ccr2
RFP/+, and Ccr2
RFP/RFP mice were bred onto the Apoe
2/2 background and fed a high-fat
diet for 8 weeks. Peripheral blood monocytes were stained for CD115, CCR2, and Ly6C and analyzed by flow cytometry. (C) Gating on monocytes. (D)
Ly6C and RFP expression of monocytes. Dashed line indicates the cutoff for a positive RFP signal. (E) Mean RFP fluorescence intensity in Ly6C
hi and
Ly6C
lo subsets. Bars indicate SEM. n=4 mice/group. P,0.008. (F) CCR2 and RFP expression of Ly6C
hi monocytes. (G) CCR2 and RFP expression in
Ly6C
lo monocytes. CCR2-positive and CCR2-negative gates were based on CCR2-deficient Ccr2
RFP/RFP mice. (H to K) Flow cytometric analysis of Ly6C,
RFP, GFP and cell-surface CCR2 expression on monocytes from Ccr2
RFP/+Cx3cr1
GFP/+ mice. CD115+ monocytes were gated (H) by Ly6C/GFP expression
and analyzed for RFP (I) and CCR2 (J) expression. Ccr2
RFP/RFPCx3cr1
GFP/+ monocytes (K) were used as a negative control for CCR2 surface-staining.
Results are representative of four mice in two similar experiments.
doi:10.1371/journal.pone.0013693.g002
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hi leukocytes accounted for
36.263.5% of total cells in Ccr2
RFP/+Cx3cr1
GFP/+ mice and
35.263.5% in Ccr2
RFP/RFPCx3cr1
GFP/+ mice (P.0.5).
To further characterize the inflammatory infiltrate, we stained
samples with antibodies against CD115 and Ly6C. Cells were
gated by CD45 expression; CD45
hi cells were then analyzed for
Figure 3. Analysis of peritoneal exudate cells from Ccr2-RFP Cx3cr1-GFP mice in a sterile peritonitis model. WT, Ccr2
RFP/+Cx3cr1
GFP/+,
Ccr2
RFP/+Cxc3r1
GFP/GFP, Ccr2
RFP/RFPCx3cr1
GFP/+, and Ccr2
RFP/RFPCx3cr1
GFP/GFP mice were injected intraperitoneally with thioglycollate, and inflammatory
exudate cells were harvested 24 h later. Cells were stained with F4/80. (A) RFP/GFP profiles of F4/80
+ peritoneal cells from naive mice (top panels) and
24 hr after injection (bottom panels). (B) Percentage of exudate cells staining positive for F4/80. Values are mean 6 SEM. n=4 mice/group. Results are
representative of two similar experiments.
doi:10.1371/journal.pone.0013693.g003
Novel CCR2-RFP Mice in EAE
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+ cells for Ly6C expression. Among
inflammatory CD45
hi cells, there were strikingly fewer CD115
+
monocytes/macrophages in the absence of CCR2 (Figure 4D). In
Ccr2
RFP/+Cx3cr1
GFP/+ mice, 88% of monocyte-lineage (CD115
+)
cells were Ly6C
hi, indicating an overwhelming advantage for this
subsetinaccessingthe CNSduringEAE(Figure 4D).InCcr2
RFP/RFP
Cx3cr1
GFP/+ mice, however, Ly6C
hi cells were drastically reduced,
both in number and as a percentage of CD45
hi infiltrating cells,
demonstrating the importance of CCR2 for recruitment of
this subset into the CNS. In contrast, accumulation of the much
less numerous Ly6C
locells was unaffected by CCR2 ablation
(Fig 4D). CCR2 deficiency led to an increase in the number of
neutrophils, from 8% to 16% of the total infiltrating cells
(Figure 4D).
Comparison of CX3CR1-GFP and CCR2-RFP fluorescence
intensities in the various CD115
+ populations from Ccr2
RFP/+
Cx3cr1
GFP/+ mice showed that Ly6C
hi cells expressed higher levels
of CCR2-RFP (P=0.016) than Ly6C
lo cells and lower levels of
CX3CR1-GFP (P=0.008) (Figure 4E). CD45
lo microglial cells
were CCR2-RFP negative at EAE peak severity and had the
highest level of CX3CR1 expression. Thus, the diversity of the
mononuclear myeloid cell infiltrate in EAE is mirrored by a
population-specific pattern of CCR2 and CX3CR1 expression,
suggesting that the Ly6C
hi/CCR2
+ and Ly6C
lo/CX3CR1
+
subsets retain functional specialization in the inflamed CNS.
Differential distribution of CX3CR1 and CCR2 in the naive
and inflamed brain
To visualize CX3CR1-and CCR2-expressing cells in the brains
of Ccr2
RFP/+Cx3cr1
GFP/+ and Ccr2
RFP/RFPCx3cr1
GFP/+ mice, we
used fluorescence microscopy. At low magnification, no RFP
signal was detected in the brains of healthy Ccr2
RFP/+Cx3cr1
GFP/+
mice (Figure 5A), although a diffuse GFP signal was visible,
corresponding to that previously attributed to resident microglia
[23]. At high magnification, RFP expression was found in
occasional perivascular cells in healthy Ccr2
RFP/+Cx3cr1
GFP/+
brains (Figures 5A and D); flow cytometry, these RFP
+ cells
accounted for ,2% of the CD45
+ marrow-derived cells in naive
brain (data not shown). Otherwise RFP expression was absent
from the parenchyma of healthy brains (Figure 5D and not
shown). RFP
+ and RFP/GFP double-positive perivascular cells
were often in close proximity (Figure 5D) and co-localized in the
perivascular zone.
As previously shown by co-localization with the microglial
marker iba-1 [28], CX3CR1-GFP was present in microglial cells
throughout the brain in both healthy and diseased tissue
(Figure 5A–F). In contrast, microglia did not express CCR2
under naive conditions or EAE-associated inflammation. These
findings were confirmed by flow cytometry (Figure 4G).
At peak EAE severity, CCR2-RFP
+ cells were present in the
perivascular and parenchymal regions of the brains of Ccr2
RFP/+
Cx3cr1
GFP/+ mice (Figure 5B), but were greatly reduced and only
found perivascularly in Ccr2
RFP/RFPCx3cr1
GFP/+ mice (Figure 5C).
RFP
+ cells accumulated in localized lesions, whereas GFP+ cells
were both widely distributed and present in clusters within the
lesions. Detailed analysis of RFP/GFP expression and cellular
morphology in the lesion cores provided further insight into the
functions of CCR2 and Ly6C
hi monocytes in EAE. The
inflammatory lesions contained CX3CR1 single-positive cells with
morphological features of activated microglia (larger cell bodies
and thicker processes, designated by an ‘‘*’’, compare Figure 5D
and 5E). In Ccr2
RFP/+Cx3cr1
GFP/+ mice, the lesion core contained
strikingly elongated CCR2-RFP
+ cells (arrow, Figure 5E) that were
notably less abundant in lesions of CCR2-deficient mice
(Figure 5F), strongly suggesting that these cells are derived from
Ly6C
hi monocytes. A number of CCR2-RFP
+ cells were also
GFP-positive, and thus appear faintly yellow (circled cells,
Figure 5E), indicating that both CCR2
+ and CCR2/CX3CR1
double-positive monocytes invade the brain parenchyma in
response to EAE. We noted that the green fluorescence in the
monocytes was much less intense than in the microglia, consistent
with the flow analysis in Figure 4G. A population of small, round
RFP
+ GFP
2 cells in EAE lesions of CCR2
+ and CCR2-deficient
mice (arrowheads, Figures 5E–F) was shown in double-labeling
experiments to be predominantly CD3
+ T cells, levels of which
were not altered by absence of CCR2 (data not shown). RFP
+ cells
in the brains of Ccr2
RFP/RFPCx3cr1
GFP/+ mice were primarily
located in the meninges, and RFP
+ cells were clearly absent from
parenchymal tissue (Figure 5F). Microglial cells near Ccr2
RFP/RFP
Cx3cr1
GFP/+ lesions displayed a less activated morphology than
microglia in Ccr2
RFP/+Cx3cr1
GFP/+ lesions (Figure 5E and 5F),
suggesting that monocytic cells in particular contribute to
activation of resident microglia.
Lack of CCR2
RFP expression by neuroepithelial cells
The findings of studies using tissue immunohistochemistry and
receptor autoradiography have suggested constitutive or inducible
expression of CCR2 by neuroepithelial cells (e.g., neurons,
astrocytes, neural stem cells) (reviewed in [31]). Aside from sparse
perivascular macrophages, we detected no CCR2-RFP
+ cells in
the CNS of healthy mice and no RFP
+ cells with neuroepithelial
morphology in the CNS of Ccr2
RFP/+ mice with EAE (Figure 5).
Furthermore, CCR2-RFP expression did not overlap with markers
of astrocytes, neurons, or oligodendrocytes (data not shown). In
analyses of CNS tissues of CCR2-RFP mice, the location and
morphology of CCR2-RFP cells provided no evidence of CCR2
expression by CNS neurons. These findings are consistent with
recent reports that peripheral nervous system but not CNS
neurons inducibly express CCR2 in pain models [32].
Three color imaging with a myeloid marker
To further analyze the identity of recruited cells, we stained
brain sections from Ccr2
RFP/+Cx3cr1
GFP/+ mice at peak EAE for
the myeloid marker 7/4. The 7/4 antigen identifies Ly6C
hi
monocytes and neutrophils, but not NK or T cells. Figure 6A
shows a periventricular lesion visualized for CCR2 (RFP, red),
CX3CR1 (GFP, green), and 7/4 (Cy5, blue). Figure 6B shows the
overlapping CX3CR1-GFP and CCR2-RFP channels only; 6C
shows CX3CR1-GFP and 7/4-blue, and 6D shows 7/4-blue and
CCR2-RFP, to allow more convenient visualization and compar-
ison of the fluorescent signals. For example, cell ‘‘1’’ in Fig. 6A is
7/4+, RFP
+ and GFP
dim, suggesting it is a Ly6C
hi monocyte that
Figure 4. CCR2-deficient mice exhibit delayed onset EAE and decreased monocyte recruitment to the CNS. (A) Ccr2
RFP/+Cx3cr1
GFP/+ and
Ccr2
RFP/RFPCx3cr1
GFP/+ mice were immunized with MOG peptide 33–55 and scored daily for neurological signs. (B) EAE symptom onset and peak
disease. (C) Total number of brain mononuclear cells and CD45
hi infiltrating cells at peak disease. (D) CD45
hi infiltrating cells were analyzed to quantify
total neutrophils (SSC
hi, CD115
2, Ly6C
lo), monocytes (CD115
+), and monocyte subsets (CD115
+/Ly6C
hi/lo), (E) CX3CR1 GFP and CCR2-RFP fluorescence
intensities in monocyte subsets and microglia. Data points represent individual mice. Values are mean 6 SEM. Results are representative of two
similar experiments.
doi:10.1371/journal.pone.0013693.g004
Novel CCR2-RFP Mice in EAE
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confirms that this cell ‘‘1’’ appears yellow (co-localized RFP-GFP),
and the green signal is best visualized in Figure 6C. Notably, the
intense GFP-green in the microglial cells makes it difficult to
visualize GFP-green signal in monocytes, without over-exposing
the microglial cells. Inspection of Figure 6D confirms that cell ‘‘1’’,
as well as the vast majority of RFP
+ cells, are 7/4
+ and thus likely
represents a classical CCR2
+ inflammatory monocyte. Cell ‘‘2’’ in
Figure 6A is 7/4
2, RFP
+, and GFP
+ and is likely a to be a
CX3CR1
hi, CCR2
lo, Ly6C
lo monocyte. Cell ‘‘3’’ is 7/4
2, RFP
+,
but GFP
2 and is interpreted as likely to be a T cell. Cell ‘‘4’’ is 7/
4
2, GFP
bright,and RFP
2 and has the morphological appearance of
a microglial cell.
Discussion
In this study we created CCR2-RFP knock-in reporter mice and
bred them with CX3CR1-GFP mice. Our goals were to quantify
CCR2 and CX3CR1 expression in defined monocyte subsets in
the blood to visualize infiltrating and resident myeloid cells in
naive and challenged mice and to determine how CCR2
contributes to the accumulation of Ly6C
hi/CCR2
+ and Ly6C
lo/
CX3CR1
+ monocytes during autoimmune tissue inflammation in
the CNS.
Circulating blood monocytes in the Ccr2
RFP/+ mice were uniformly
positive for RFP by FACS, and approximately 80% expressed cell-
surface CCR2, whereas CCR2 surface-negative monocytes were
predominantly Ly6C
lo, as expected. Mean RFP intensity was
approximately twofold higher in Ly6C
hi than Ly6C
lo monocytes,
consistent with reports of relative CCR2 mRNA levels in these
populations [3]. The presence of RFP in Ly6C
lo monocytes that
expressed little or no surface CCR2 protein (.80% of monocytes in
this population) raised the possibility that CCR2 was present in the
cytoplasm but failed to traffic to the cell surface. However,
permeabilization experiments with Ly6C
lo monocytes did not reveal
substantial intracellular stores of CCR2. Thus, Ly6C
lo monocytes
transcribe CCR2 but fail to translate it into protein. Similar results
were seen in NK cells and T cells (data not shown). Additional signals
might initiate CCR2 translation in these monocytes and thus provide
the potential to rapidly upregulate CCR2 expression.
To investigate the functions of monocyte subsets, we crossed the
CCR2-RFP mice with CX3CR1-GFP knock-in mice [23] to
create Ccr2
RFP/+Cx3cr1
GFP/+ mice. These ‘‘two-color’’ mice were
examined in three pathological settings: Apoe deficiency on a high-
fat diet, thioglycollate induced-peritonitis (localized sterile acute
inflammation), and EAE (localized organ-specific autoimmune
inflammation). Overall, the findings support the notion that CCR2
and CX3CR1 define functionally distinct monocyte subsets and
Figure 5. Expression of CX3CR1 and CCR2 in brain lesions of mice with EAE. (A–C) Low-magnification epifluorescence images of naive
Ccr2
RFP/+Cx3cr1
GFP/+ (A), diseased Ccr2
RFP/+Cx3cr1
GFP/+ (B), and Ccr2
RFP/RFPCx3cr1
GFP/+ (C) brains show the extent of inflammation and anatomical
location of the lesions. Higher magnification views of the boxed areas are shown in panels D–F. Confocal image of healthy perivascular (D) tissue
shows GFP
+ microglia (asterisks), small round RFP
+ cells (arrowhead), and double-positive cells (circles). (E) Parenchymal lesion ina Ccr2
RFP/+Cx3cr1
GFP/+
mouse and (F) a perivascular lesion from a Ccr2
RFP/RFPCx3cr1
GFP/+ mouse at peak EAE disease. Dashed line in (F) indicates the approximate perivascular
boundary. Within EAE lesions, note RFP/GFP double-positive cells (circles), GFP
+ activated microglia (E, F; asterisks), large elongated RFP
+ cells (E, F;
arrows), and small round RFP
+ cells (E, F; arrowheads). Small RFP
+ cells were CD3
+ (not shown). The particularly elongated RFP
+ cells in the Ccr2
RFP/+
Cx3cr1
GFP/+ lesion (E) were much less abundant in the Ccr2
RFP/RFPCx3cr1
GFP/+ lesion (F).
doi:10.1371/journal.pone.0013693.g005
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in situ within brain infiltrates.
Under the steady-state, low-level inflammatory conditions of a
high-fat diet, Ly6C
hi monocytes had higher RFP intensity and
lower GFP intensity than Ly6C
lo cells, allowing the subsets to be
clearly distinguished by their RFP/GFP profiles. To investigate
the trafficking of monocyte subsets in an acute inflammatory
model, we used thioglycollate to induce sterile peritonitis. At 24 h,
the vast majority of monocyte/macrophages recruited to the
peritoneum in Ccr2
+/RFPCx3cr1
+/GFP mice expressed RFP and
GFP. Because CCR2 is rapidly downregulated when monocytes
differentiate into macrophages [33], these results suggest that the
RFP
hi cells were newly arrived monocyte/macrophages and show
that the RFP and GFP markers are useful for tracking migrating
monocytes. Interestingly, the absence of CX3CR1 in the Ccr2
RFP/+
Cx3cr1
GFP/GFP mice had little or no effect on the RFP/GFP profile
or the number of recruited cells. By contrast, deletion of CCR2 in
Ccr2
RFP/RFPCx3cr1
+/GFP mice drastically reduced peritoneal mac-
rophage recruitment.
CCR2 and CX3CR1 have been implicated as disease modifiers
in EAE, a model for the inflammatory aspects of multiple sclerosis.
EAE severity is restricted in CCR2-deficient mice on a mixed
C57Bl/6 and 129/J background and in CCL2-deficient (MCP-1/
JE) mice [34–36]. It has been proposed that CCR2
+ monocytes
that enter the CNS during EAE differentiate into macrophages
and DCs, thereby promoting EAE pathogenesis [17,37]. In
contrast, CX3CR1 deficiency exacerbates EAE because regulatory
NK cells are not recruited to the inflamed CNS [26].
Our EAE experiments revealed physiologically relevant and
mechanistically intriguing functions of CCR2 expression and
regulation of CNS myeloid inflammation. We predicted that
CCR2 deficiency would preferentially reduce Ly6C
hi monocyte
infiltration into the CNS of mice with EAE. To test this hypothesis,
we compared the pathogenesis of EAE in Ccr2
RFP/+Cx3cr1
GFP/+
and CCR2-deficient Ccr2
RFP/RFPCx3cr1
GFP/+ mice. Mice deficient
in both CCR2 and CX3CR1 (Ccr2
RFP/RFPCx3cr1
GFP/GFP mice) were
included to probe the interactions between these receptors in EAE.
As predicted, Ly6C
hi monocytes were virtually absent from the
CNS of the Ccr2
RFP/RFPCx3cr1
GFP/+ mice with EAE. Unexpected-
ly, the total numbers of leukocytes infiltrating the CNS were
indistinguishable in control and CCR2-deficient mice. Detailed
analysis of CNS infiltrates by flow cytometry and fluorescence
Figure 6. Analysis of monocyte subsets in brain lesions of EAE Ccr2
RFP/+Cx3cr1
GFP/+ mice at peak EAE. Confocal images of the
periventricular lesions were obtained after staining with the 7/4 antibody. Images represent the same lesion (A) Merged images of red/CCR2, green/
CX3CR1, and blue/7/4. (B) Red/CCR2 and green/CX3CR1. (C) Blue/7/4 and green/CX3CR1. (D) Red/CCR2 and blue/7/4. The majority of CCR2
+ cells are
7/4
+ and CX3CR1
lo or negative, suggesting that they are classical infiltrating monocytes (see individual cell ‘‘1’’). Ly6C
lo monocytes (CX3CR1
hi and
CCR2) are also present (cell ‘‘2’’), as well as T cells (‘‘3’’) and activated microglial cells (‘‘4’’).
doi:10.1371/journal.pone.0013693.g006
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populations in the CNS.
First, by evaluating monocyte/macrophage/microglial chemo-
kine receptor expression in EAE infiltrates, we found that CD45
lo
microglia invariably expressed CX3CR1 but not CCR2 in both
healthy and diseased CNS tissues. Thus, CCR2-RFP and
CX3CR1-GFP can differentiate resident microglia (GFP only)
from infiltrated monocyte-derived cells (RFP
+ with various degrees
of GFP expression). Resident microglia and infiltrating monocyte-
derived macrophages fulfill very different functions, as most
pointedly indicated by analysis of their functions in Alzheimer’s
disease models [38]. Therefore, the capacity to distinguish resident
microglia from infiltrating monocytes will be valuable for
functional characterizations.
Second, neutrophils, not Ly6C
lo monocytes, replaced Ly6C
hi
monocytes in the brains of Ccr2
RFP/RFPCx3cr1
GFP/+ mice with
EAE, accounting for the equivalent number of total leukocytes.
Thus, our findings reveal that Ly6C
lo/CX3CR1
+ monocytes are
relatively excluded from the inflamed CNS of mice with EAE,
regardless of CCR2 expression. Therefore, Ly6C
hi and Ly6C
lo
monocytes do no appear to contribute sequentially to tissue
inflammation or tissue remodeling/repair in the CNS as reported
in cardiac ischemic injury (16). We propose that endogenous
microglia perform the repair and remodeling functions carried out
by Ly6C
lo monocytes in peripheral organs. Thus, CCR2
antagonists [39] will likely affect CCR2
+ infiltrating monocytes
but not resident CX3CR1
+ microglia.
A third major finding, made possible by the use of RFP as a
surrogate marker for CCR2, was that the absence of CCR2
prevents monocytes from leaving the vasculature and entering the
perivascular space. There is considerable controversy regarding
whether CCR2 mediates monocyte trafficking out of hematopoi-
etic organs into the blood, trafficking from blood to inflamed
organs, or both [12,13]. CCR2 ligands, such as MCP-1, are made
by parenchymal cells of the CNS [40], consistent with the
hypothesis that the CCL2/CCR2 axis is critical for monocyte
recruitment to the inflamed CNS from the blood [41].
Finally, RFP and GFP expression in infiltrated cells in the CNS
overlapped with the patterns observed in the blood. In particular,
mononuclear cells in the perivascular region of the brain displayed
a range of RFP/GFP ratios consistent with those in the blood
(Figures 2 5, and 6). For example, in FACS analyses, Ly6C
hi cells
in the diseased CNS of Ccr2
RFP/+Cx3cr1
GFP/+ mice with EAE were
RFP
hi and GFP
med/lo, while the infrequent Ly6C
lo cells were
GFP
hi/RFP
lo (Figure 2I). We used 7/4 as a surrogate for Ly6C
staining in brain sections and found a corresponding correlation
between the presence of RFP and GFP depending on the 7/4
status of the monocyte (Figure 6).
In Ccr2
RFP/RFPCx3cr1
GFP/+ mice, the onset of EAE occurred 5
days later than in Ccr2
RFP/+Cx3cr1
GFP/+ control mice, but reached
similar peak severity with the same kinetics as in littermate
controls. The delay in EAE development was presumably due to
the absence of CCR2
+ monocytes in the CNS. Their particular
contribution is a subject of future work, but it has been suggested
that they express inflammatory mediators and can convert to DCs
[17,37]. In support of this hypothesis, CCR2-deficient mice had
50% fewer CD11c+ cells in the brain with EAE, as compared with
CCR2+ mice at the same sate of disease (unpublished data).
Spinal cord total inflammatory burden was not affected by
CCR2 deficiency (Figure S2). This finding most likely accounts
f o rt h es i m i l a rp e a kd i s e a s es e v e r i t yi nt h eCcr2
+/RFP and
Ccr2
RFP/RFP mice, since the neurological signs of EAE arise from
spinal-cord involvement [30]. These results generally corre-
spond to those reported in CCL2 knockout mice [35]. However,
in the current study, we analyzed fully-back-crossed knockout
mice at 24 weeks of age, which may explain the differences in
neurobehavioral results between our studies and some previous
studies [34,36,42]. In double-receptor knockout mice (Ccr2
RFP/RFP
Cx3cr1
GFP/GFP), neurological signs of EAE were indistinguishable
from those of CCR2-deficient Ccr2
RFP/RFPCx3cr1
+/GFP mice,
indicating that CCR2 plays a dominant role in EAE severity (data
not shown).
There are several limitations to the usefulness of this model for
in vivo imaging. First, because some T cells and NK cells express
CCR2 transcripts and are thus RFP-positive, it is not possible to
conclude that all red cells in an image are monocytes. Depending
on the specific setting, additional markers may have to be
included to allow more precise identification of the cells, as
illustrated in the EAE experiments in Figure 6, in which we found
that the vast majority, but not all RFP
+ cells were also 7/4
+.I n
addition, although RFP intensity correlates well with Ly6C
intensity, the overlap is not perfect, and some RFP
bright cells may
be Ly6
lo. Nonetheless, the ability to simultaneously image CCR2
and CX3CR1 expression in monocytes and other leukocytes
represents a powerful new tool for investigating complex
pathophysiology.
In summary, our findings confirm, refine, and extend the
concept of monocyte heterogeneity. We created and characterized
a transgenic mouse model that allows simultaneous tracking of two
key chemokine receptors, CCR2 and CX3CR1 and enumeration
of distinct monocyte and myeloid subsets based on CCR2-RFP/
CX3CR1-GFP expression. We showed that CCR2 expression is
controlled at a post-transcriptional stage in some Ly6C
lo
monocytes and NK and T cells. We found that Ly6C
hi monocytes
fail to enter the CNS of CCR2deficient mice during EAE and are
mainly replaced by neutrophils, not Ly6C
lo monocytes. We
hypothesize that CCR2
+ Ly6C
hi monocytes initiate and maintain
neuroinflammatory responses, while tissue remodeling is mediated
by CX3CR1
+ microglia. The CCR2-RFP/CX3CR1-GFP report-
er mice should be useful for studying the roles of CCR2 and
CX3CR1 in myeloid cell recruitment in a wide range of
inflammatory diseases. The expression of CCR2 transcripts in
some NK and T cells is of interest and must be taken into account
when using this model.
Materials and Methods
Ethics Statement
All animals were handled in strict accordance with good animal
practice as defined by the relevant national and/or local animal
welfare bodies, and all animal work was approved by the
appropriate committees: IACUC University of California, San
Francisco APPROVAL NUMBER: AN079763-02; IACUC
Cleveland Clinic APPROVAL NUMBER: ARC 07541; IACUC
University of Texas, San Antonio APPROVAL NUMBER:
MU060-08/12A0.
Mice
CCR2
RFP mice were created as described [25] (see Figure 1 and
Text S1). Founder mice were crossed with Cre-deleter mice [43] to
remove the neo gene and backcrossed onto the C57Bl/6 line nine
times. To generate homozygous Ccr2
RFP/RFPCx3cr1
GFP/GFP mice,
we crossed Ccr2
RFP/RFP with Cx3cr1
GFP/GFP C57Bl/6 mice (a gift of
D.R. Littman), and the progeny were backcrossed onto C57Bl/6.
Mice that had undergone chromosome recombination between
the CCR2 and CX3CR1 loci were selected by being positive for
both RFP and GFP by flow cytometry of tail vein blood.
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times on C57Bl/6 and were 2–6 months of age at sacrifice. Some
mice were crossed with C57Bl/6 Apoe
2/2 mice. These mice were
fed a Western diet (42% of calories from fat) (Harlan Teklad,
TD88137) for 8 weeks, starting at 6–8 weeks of age. All other mice
were fed standard chow. Mice were bred at the Gladstone
Institutes and the Biological Resources Unit, Cleveland Clinic,
Lerner Research Institute. Animal experiments were performed
according to the protocols approved by the Institutional Animal
Care and Use Committee at the Cleveland Clinic, UCSF, and
UTSA following the National Institute of Health guidelines for
animal care. Mice were genotyped by PCR using tail DNA, and
chemokine receptor–specific primers (Invitrogen, Carlsbad,CA)
(Table S1).
EAE induction
At 12–24 weeks of age, EAE was induced in male and female
mice weighing less than 32 g as described [26] and monitored for
signs of disease as described [35]: 0, no disease; 1, decreased tail
tone and/or poor righting ability; 2, abnormal gait and/or hind
limb weakness; 2.5, partial hind limb paralysis; 3, complete hind
limb paralysis; 3.5, ascending paralysis; 4, tetraplegia; 5, death.
Mice were sacrificed at a score of 3–4.
Microscopy
Brains and spinal cords were either perfused with phosphate-
buffered saline (PBS) and frozen whole in OCT or perfused with
or 4% PFA and processed into free-floating 30-mm sections, as
described [26]. Sections were stained for CD45, as described [44].
For details on histological methods, please see Text S1. To
visualize the distribution of cells expressing GFP (CX3CR1) and
RFP (CCR2), free-floating sections were stained with 15 nM
DAPI for 5 min, and whole-brain sections were scanned using a
Leica DM5500B with motorized x,y stage. High-power confocal
images are shown as projections of 7–10-mm z stacks at 40x
magnification and scanned at a step size of 1–1.5 mm. In some
experiments, brain sections were incubated overnight at 4uC with
7–4 antibody (Cedarlane, Ontario, Canada), washed, and
incubated at room temperature for 2 h with biotinylated-rabbit
anti rat secondary antibody (Jackson ImmunoResearch). After
additional washes, tissues were incubated at room temperature for
1 h with strepatvidin-Cy5 conjugated, rinsed and mounted in
Fluorsave reagent (Calbiochem). Tissues were imaged at 40x
magnification on a Zeiss 510 confocal microscope.
Flow cytometry
For flow cytometric analysis of CNS tissues, mice were perfused
with cold Hank’s balanced salt solution. The brains were dissected
and the spinal cords were flushed with 0.5 ml of cold PBS. Tissues
were homogenized with Dounce homogenizers, and cells were
separated in a discontinuous 30/70 Percoll gradient [45]. Cells
were collected from the 30/70 interphase and washed in PBS.
Blood was collected by cardiac puncture of anesthetized mice
,
depleted of red blood cells in lysis buffer (0.15 mol/l NH4Cl,
1 mmol/l KHCO3, 0.1 mmol/l EDTA), and washed in staining
buffer (PBS/0.1% BSA). For flow details, please see Text S1.
Sterile peritonitis model
Peritonitis was induced with thioglycollate as described [25].
Peritoneal leukocytes were collected 24 h later by flushing the
peritoneal cavity with 10 ml of PBS. Peritoneal cells were washed
with staining buffer and stained for F4/80 and 7-4 as described
above.
Quantitative RT-PCR
RNA was isolated from FACS-sorted cell populations with the
Arcturus PicoPure kit (Molecular Devices, Sunnyvale, CA)
according to the manufacturer’s instructions. Quantity was
assessed with a Nanodrop 1000, and RNA was reverse
transcribed with TaqMan reverse-transcription reagents. Quan-
titative real-time PCR was carried out with TaqMan PCR
Master Mix, TaqMan gene expression assays, and an Applied
Biosystems 7900HT thermal cycler. All TaqMan reagents were
from Applied Biosystems. Reactions were run in quadruplicate,
and CCR2 and RFP mRNA expression levels were normalized to
beta-actin.
Statistical analysis
Data are presented as mean 6 SEM. Differences between
Cx3cr1
+/2Ccr2
+/2 and Cx3cr1
+/2Ccr2
2/2 mice were analyzed
with a two-tailed nonparametric Mann-Whitney test.
Supporting Information
Text S1 Supporting Materials and Methods.
Found at: doi:10.1371/journal.pone.0013693.s001 (0.03 MB
DOC)
Table S1 Primers used for tail-DNA genotyping. *Primers A-B
amplify the wild type allele, whereas primers B-C identify the
knockout allele.
Found at: doi:10.1371/journal.pone.0013693.s002 (0.03 MB
DOC)
Figure S1 Analyses of cytoplasmic CCR2. WT, Ccr2RFP/+,
and Ccr2RFP/RFP mice were bred onto the Apoe2/2
background and fed a high-fat diet for 8 weeks. Intact and
permeabilized monocytes, identified by CD115 staining, were
stained for CCR2 and Ly6C. Boxes indicate demarcation of
monocytes into Ly6Chi and Ly6Clo populations. Dashed line
indicates the cutoff for positive CCR2 staining, using Ccr2RFP/
RFP cells as the negative control. Permeabilization did not
increase background staining in the CCR2 knockout mice (not
shown). Results are representative of four experiments.
Found at: doi:10.1371/journal.pone.0013693.s003 (0.50 MB
EPS)
Figure S2 Analysis of spinal inflammation in CCR2-deficient
mice. Spinal cord tissues were fixed and stained with anti-CD45
antibodies to compare the distribution of inflammatory cells in
double heterozygous Ccr2RFP/+ Cx3cr1GFP/+ mice (A,B) and
Ccr2RFP/RFP Cx3cr1GFP/+ mice (C,D) at peak EAE disease.
The extent of disease was similar in both genotypes. WM: white
matter. GM: gray matter.
Found at: doi:10.1371/journal.pone.0013693.s004 (1.97 MB
EPS)
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